FDA Details Procedures to Approve Emergency Research Without Informed Consent

Drug Industry Daily
A A
The FDA Monday issued new requirements for emergency research on incapacitated patients, stressing that sponsors must search for a patient’s family to seek permission to continue any trial started without consent and allow patients to opt out once they’re conscious.

To View This Article:

Login

Subscribe To Drug Industry Daily